Valley View company begins clinical study with University of Cincinnati

A few weeks after receiving additional patent coverage, Great Lakes NeuroTechnologies has launched a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The NIH-funded study is being conducted in partnership with Dr. Alberto Espay of the University of Cincinnati and Dr. Peter LeWitt of HenryFord Health System in Detroit.

Researchers and companies around the world are investigating new treatments intended to slow the progression of PD. Demonstrating the efficacy of these types of proposed neuroprotective therapies can be challenging since very small changes over long periods of time must be measured. The current standard for evaluation of PD motor symptom severity and progression is the Unified Parkinson’s Disease Rating Scale (UPDRS), a subjective scoring system relying on clinician observations to rate symptom severity on 0-4 scale.

Using a system like Kinesia, with high sensitivity motion sensors to measure those changes, can provide several advantages when combined with clinical rating scales. As a unique part of the study design, Parkinson’s patients implanted with deep brain stimulation devices will be recruited for the study. Slowly adjusting the stimulation settings will allow researchers to simulate worsening symptoms and disease progression that would normally take years to study.

Learn more about the clinical study in the company’s press release.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

University of Toledo Medical Center’s new $36M simulator makes training nearly real | Toledo Blade, April 23, 2014

Aerpio Therapeutics closes $22M financing led by OrbiMed (pdf) | Aerpio Therapeutics, April 23, 2014

CTI Clinical Trial & Consulting Services continues to grow with promotions and new hires | Cincinnati.com, April 22, 2014

Austen BioInnovation Institute in Akron presenting two FDA events in one day, April 29 | Austen BioInnovation Institute in Akron, April 22, 2014

OSU collaboration with California’s Oakbio awarded $500k from Canada’s CCEMC to develop biofuels | PR Newswire, April 22, 2014

OSU students’ non-polluting KAir battery wins $100K from US DOE | Columbus Business First, April 22, 2014

The Medical Imaging Technology Partnering Forum part of Cleveland’s medical imaging strength | Cleveland.com, April 22, 2014

Akebia Therapeutics stock rose 55% last week, from below $17 to above $26 | Cincinnati Business Courier, April 21, 2014

The Austen BioInnovation Institute in Akron working with Nottingham Spirk, a Cleveland-based design firm | Akron Beacon Journal, April 21, 2014

CincyTech discusses recent funding for Assurex Health & Sirrus (Bioformix) | Cincinnati Business Courier, April 21, 2014

Akron Children’s joins with Cincinnati Children’s to offer access to new cancer treatments | Akron Beacon Journal, April 20, 2014

OSU Biomedical Engineering students and OncoFilter partners Kinshuk Mitra and Brett Geiger featured on 10TV Columbus | WBNS 10TV Columbus, April 19, 2014

Case Western Reserve University event emphasizes a constellation of research (slideshow) | Cleveland.com, April 19, 2014

Airway Therapeutics granted orphan designation for its product to prevent BPD by European regulatory authority | Cincinnati.com, April 19, 2014

Assurex Health and Sirrus (Bioformix) lead 2014 Q1 funding rounds | Cincinnati.com, April 18, 2014

PhRMA Annual Meeting keynote speakers available on YouTube | PhRMA, April 18, 2014

Alkermes CEO Richard Pops speaks with Xconomy about building the business | Xconomy.com, April 18, 2014

Case Western Reserve University scientists discuss a portable malaria detector (video) | Inside Science TV, April 18, 2014

Ashland University Schar Nursing College starts Doctor of Nursing Program | WMFD Mansfield, April 18, 2014

Kent State Researchers discover new liquid crystal structure | Kent State University, April 17, 2014